🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
26.69
+0.28 (1.06%)
Nov 18, 2026, 4:00 PM EST - Market closed

Stoke Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
28.21184.4236.568.7812.41-
Revenue Growth
-86.28%404.50%316.34%-29.22%--
Gross Profit
28.21184.4236.568.7812.41-
Selling, General & Admin
95.1167.0948.7941.3238.9231.9
Research & Development
190.7137.9289.1382.2377.8454.17
Operating Expenses
285.81205.01137.93123.55116.7686.07
Operating Income
-257.6-20.59-101.37-114.77-104.36-86.07
Interest Expense
-0.06-0.01-0.03-0.05--
Interest & Investment Income
14.2413.7712.669.963.120.12
Other Non Operating Income (Expenses)
0.22-0.05-0.250.170.170.14
Pretax Income
-243.2-6.89-88.98-104.7-101.07-85.81
Net Income
-243.2-6.89-88.98-104.7-101.07-85.81
Net Income to Common
-243.2-6.89-88.98-104.7-101.07-85.81
Net Income Growth
------
Shares Outstanding (Basic)
655954443937
Shares Outstanding (Diluted)
655954443937
Shares Change
8.94%9.65%22.76%13.11%5.87%9.71%
EPS (Basic)
-3.75-0.12-1.65-2.38-2.60-2.34
EPS (Diluted)
-3.75-0.12-1.65-2.38-2.60-2.34
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-215.7244.92-87.05-82.68-35.83-68.11
Free Cash Flow Per Share
-3.330.76-1.61-1.88-0.92-1.85
Gross Margin
100.00%100.00%100.00%100.00%100.00%-
Operating Margin
-913.16%-11.16%-277.31%-1307.21%-841.24%-
Profit Margin
-862.10%-3.73%-243.42%-1192.47%-814.73%-
Free Cash Flow Margin
-764.69%24.36%-238.15%-941.72%-288.82%-
EBITDA
-255.84-18.82-99.2-112.3-102.81-85.09
EBITDA Margin
--10.21%-271.36%---
D&A For EBITDA
1.761.772.182.471.550.97
EBIT
-257.6-20.59-101.37-114.77-104.36-86.07
EBIT Margin
--11.16%-277.31%---
SEC Filings: 10-K · 10-Q